Literature DB >> 2468163

cAMP and forskolin decrease gamma-aminobutyric acid-gated chloride flux in rat brain synaptoneurosomes.

G Heuschneider1, R D Schwartz.   

Abstract

The effects of the cyclic nucleotide cAMP on gamma-aminobutyric acid-gated chloride channel function were investigated. The membrane-permeant cAMP analog N6,O2'-dibutyryladenosine 3',5'-cyclic monophosphate inhibited muscimol-induced 36Cl- uptake into rat cerebral cortical synaptoneurosomes in a concentration-dependent manner (IC50 = 1.3 mM). The inhibition was due to a decrease in the maximal effect of muscimol, with no change in potency. Similar effects were observed with 8-(4-chlorophenylthio)adenosine 3',5'-cyclic monophosphate, 8-bromoadenosine 3',5'-cyclic monophosphate, and the phosphodiesterase inhibitor isobutylmethylxanthine. The effect of endogenous cAMP accumulation on the gamma-aminobutyric acid-gated Cl- channel was studied with forskolin, an activator of adenylate cyclase. Under identical conditions, in the intact synaptoneurosomes, forskolin inhibited muscimol-induced 36Cl- uptake and generated cAMP with similar potencies (IC50 = 14.3 microM; EC50 = 6.2 microM, respectively). Surprisingly, 1,9-dideoxyforskolin, which does not activate adenylate cyclase, also inhibited the muscimol response, suggesting that forskolin and its lipophilic derivatives may interact with the Cl- channel directly. Indeed, forskolin inhibition of muscimol-induced 36Cl- uptake was extremely rapid (within 5 sec), preceding the accumulation of sufficient levels of cAMP. After 5 min, a slower phase of inhibition was seen, similar to the time course for cAMP accumulation. The data suggest that gamma-aminobutyric acid (GABAA) receptor function in brain can be regulated by cAMP-dependent phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468163      PMCID: PMC287035          DOI: 10.1073/pnas.86.8.2938

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  Glutamate and gamma-aminobutyric acid in brain.

Authors:  K Krnjević
Journal:  Nature       Date:  1970-10-10       Impact factor: 49.962

2.  The role of hormone receptors and GTP-regulatory proteins in membrane transduction.

Authors:  M Rodbell
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

Review 3.  Desensitization of GABA receptors.

Authors:  K Krnjević
Journal:  Adv Biochem Psychopharmacol       Date:  1981

4.  Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.

Authors:  J F Harper; G Brooker
Journal:  J Cyclic Nucleotide Res       Date:  1975

5.  A cyclic nucleotide-gated conductance in olfactory receptor cilia.

Authors:  T Nakamura; G H Gold
Journal:  Nature       Date:  1987 Jan 29-Feb 4       Impact factor: 49.962

6.  3H-baclofen and 3H-GABA bind to bicuculline-insensitive GABA B sites in rat brain.

Authors:  D R Hill; N G Bowery
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962

7.  Serotonin and cyclic AMP close single K+ channels in Aplysia sensory neurones.

Authors:  S A Siegelbaum; J S Camardo; E R Kandel
Journal:  Nature       Date:  1982-09-30       Impact factor: 49.962

Review 8.  Forskolin: a unique diterpene activator of cyclic AMP-generating systems.

Authors:  K B Seamon; J W Daly
Journal:  J Cyclic Nucleotide Res       Date:  1981

9.  cAMP-dependent protein kinase phosphorylates the nicotinic acetylcholine receptor.

Authors:  R L Huganir; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

10.  Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein.

Authors:  K Seamon; J W Daly
Journal:  J Biol Chem       Date:  1981-10-10       Impact factor: 5.157

View more
  20 in total

1.  High doses of simvastatin upregulate dopamine D1 and D2 receptor expression in the rat prefrontal cortex: possible involvement of endothelial nitric oxide synthase.

Authors:  Qing Wang; Wee Lee Ting; Hongyuan Yang; Peter T-H Wong
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

2.  Modulation of synaptic GABAA receptor function by PKA and PKC in adult hippocampal neurons.

Authors:  P Poisbeau; M C Cheney; M D Browning; I Mody
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

3.  Protein kinase C and cAMP-dependent protein kinase phosphorylate the beta subunit of the purified gamma-aminobutyric acid A receptor.

Authors:  M D Browning; M Bureau; E M Dudek; R W Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 4.  Molecular and cellular mechanisms of GABA/benzodiazepine-receptor regulation: electrophysiological and biochemical studies.

Authors:  M Farrant; T T Gibbs; D H Farb
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

5.  Calcium- and cyclic-AMP-mediated secretory responses in isolated colonic crypts.

Authors:  M Böhme; M Diener; W Rummel
Journal:  Pflugers Arch       Date:  1991-09       Impact factor: 3.657

6.  Changes in [3H]forskolin binding to adenylate cyclase and [3H]phorbol dibutyrate binding to protein kinase C in pentobarbital tolerant/dependent rats.

Authors:  S Oh; S E Wellman; I K Ho
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

Review 7.  Ethanol, gamma-aminobutyrate type A receptors, and protein kinase C phosphorylation.

Authors:  R L Macdonald
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

8.  Beta-adrenergic enhancement of inhibitory synaptic activity in rat cerebellar stellate and Purkinje cells.

Authors:  I Llano; H M Gerschenfeld
Journal:  J Physiol       Date:  1993-08       Impact factor: 5.182

9.  Facilitation of GABAergic signaling in the retina by receptors stimulating adenylate cyclase.

Authors:  A Feigenspan; J Bormann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  Experimental status epilepticus alters gamma-aminobutyric acid type A receptor function in CA1 pyramidal neurons.

Authors:  J Kapur; D A Coulter
Journal:  Ann Neurol       Date:  1995-12       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.